News
IGC Pharma partners with University of Los Andes, to leverage AI for improving Alzheimer's disease treatment and clinical trial efficiency.
India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease ...
About 350 staff at the University of Edinburgh have accepted voluntary redundancy as part of a cost-saving effort. In a letter to staff, principal Sir Peter Mathieson also confirmed academic ...
About IGC: India Globalization Capital, Inc. (IGC) engages in the development of cannabinoid-based therapies for indications such as Alzheimer's disease and pain.
IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 study in subjects with dementia from Alzheimer’s disease.
More than £12 million in funding was handed to the University of Edinburgh by organisations with affiliations to the Chinese military over the past five years, a report has revealed.
The positions in the table below reflect the The University of Edinburgh's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position ...
The original patent application was initiated by the University of South Florida (“USF”) and filed on August 1, 2016. On May 25, 2017, IGC entered into an exclusive license agreement with USF ...
Lecturers at the University of Edinburgh are set to walk out in a dispute over the university's refusal to rule out "unacceptable" compulsory redundancies as part of plans to save £140 million.
The University of Edinburgh is cutting £140m from its budget, which a union describes as a "manufactured crisis".
In 2017, IGC acquired a patent filing from the University of South Florida (USF) that showed that micro-doses of cannabis in combination with other natural compounds are beneficial to Alzheimer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results